GENEROSO MASANGKAY: Open Payments
NPI 1407823552 · FORT WALTON BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,398 in 71 payments from 10 companies in 2025. Trend: 2023 $1,568 · 2024 $1,332 · 2025 $2,398
Food & beverage: $2,398
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 19 | $445 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $408 |
| Teva Pharmaceuticals USA, Inc. | 10 | $372 |
| Vanda Pharmaceuticals Inc. | 4 | $250 |
| Otsuka America Pharmaceutical, Inc. | 9 | $248 |
| Alkermes, Inc. | 4 | $192 |
| ABBVIE INC. | 9 | $168 |
| Neurocrine BioSciences, Inc. | 3 | $157 |
| Janssen Pharmaceuticals, Inc | 5 | $132 |
| Lundbeck LLC | 1 | $26 |
Products named: COBENFY, CAPLYTA, REXULTI, FANAPT, UZEDY, ARISTADA, VRAYLAR, INGREZZA.
Industry payments across FL — which companies pay providers there.
